NRC Health’s Human Understanding Beyond | HUB24 offers an opportunity to explore cutting-edge solutions, best practices, and forward-thinking strategies aimed at enhancing experiences for patients, consumers, and employees. In an ever-evolving healthcare landscape, hospitals and health systems must adapt to…
On Saturday, June 22, 2024, RHÖN-KLINIKUM Campus Bad Neustadt will host the fifth annual Prevention and Health Day from 10 a.m. to 3 p.m. The event promises a diverse array of activities including specialist lectures, informational booths, workshops, and hands-on…
Adjuvant chemotherapy, also known as preventive chemotherapy, is a critical component in the comprehensive treatment of cancer. It involves administering chemotherapeutic agents after primary treatment, typically surgery, to eliminate any remaining cancer cells and reduce the risk of recurrence (Osorio,…
Maddie Davidson, the first female trampolinist to represent New Zealand at the Tokyo 2020 Olympic Games (held in 2021), recently captivated residents of Kevin Hickman Village with insights into her preparations for the Paris 2024 Olympics. With just six weeks…
Premier, Inc. (NASDAQ: PINC), a leading technology-enabled healthcare improvement company, has been named one of the Best Companies to Work For in 2024-2025 by U.S. News & World Report for the second consecutive year. The company received top marks for…
Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, has announced that its Board of Directors has appointed Charles “Chuck” Divita, III, as Chief Executive Officer, effective immediately. Along with his new role as CEO, Mr. Divita…
The medical team at Al-Mouwasat Hospital in Al-Khobar successfully saved the life of a patient suffering from severe abdominal pain and bleeding. Upon the patient’s arrival, having been transferred from another hospital, the emergency department’s medical team conducted a clinical…
Celltrion Reveals Positive Phase III Data for CT-P47 Biosimilar at EULAR 2024 Celltrion presented encouraging Phase III data for CT-P47, a biosimilar candidate referencing RoActemra® in patients with moderate to severe rheumatoid arthritis (RA) at the Annual European Congress of…
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a leading oncology firm, and NewBridge Pharmaceuticals have mutually decided to conclude their partnership in the MENA region. This strategic move is aligned with BeiGene’s aim to directly manage its operations in the…
At the European Hematology Association (EHA) 2024 Hybrid Congress, the data from InnoCare’s (HKEX: 09969; SSE: 688428) robust pipelines were presented, showcasing significant advancements in various areas of hematology research and treatment. About InnoCare:InnoCare (HKEX: 09969; SSE: 688428) is a…
A recent survey conducted by Miracle-Ear, an Amplifon company, delved into the impact of hearing loss on the Gen X and Baby Boomer populations, aged 44 to 78. With data from 1,000 U.S. adults, the survey highlights significant findings regarding…
A recent study of Phoenix’s bioscience ecosystem has pinpointed three areas poised for significant growth and global impact, centered around the Phoenix Bioscience Core and surrounding regional hubs of research and innovation. The report, titled “Leveraging the Phoenix Region’s Bioscience…